| jensen, michael g |
NCT06233461: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease |
|
|
| Recruiting | 2 | 268 | Europe, Canada, Japan, US, RoW | TAK-279, Zasocitinib, Placebo | Takeda | Crohn's Disease | 09/26 | 07/27 | | |
| Recruiting | 1 | 32 | US | Niacin | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Excessive Weight Gain | 05/27 | 05/27 | | |
| Recruiting | 1 | 48 | US | Insulin | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Obesity | 06/28 | 06/28 | | |
NCT03867500: Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes Mellitus |
|
|
| Completed | 1 | 12 | US | Niacin, Saline | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 2 Diabetes Mellitus, Obesity | 12/21 | 12/21 | | |
NCT06416969: Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation |
|
|
| Not yet recruiting | 1 | 24 | US | Somatostatin, Epinephrine | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Obesity | 04/27 | 04/27 | | |
NCT03866408: Insulin Regulation of Lipolysis and Lipolysis Proteins |
|
|
| Recruiting | 1 | 64 | US | Immediate weight loss, Pioglitazone, Deferred weight loss, Placebo | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Obesity | 12/24 | 12/24 | | |
NCT03435016: A Comparative Study of MRI, US and CE for Assessing Treatment Response in Known Crohn's Disease |
|
|
| Completed | N/A | 62 | Europe | Diagnostic work-up, Ileocolonoscopy, MR enterocolonography, Ultrasound, Small bowel colon capsule endoscopy | Sygehus Lillebaelt, Odense University Hospital, Hospital of South West Jutland | Crohn Disease | 03/23 | 06/23 | | |
NCT03818178: Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids |
|
|
| Recruiting | N/A | 60 | US | Intralipid, Palm Oil Emulsion, Saline | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Insulin Resistance | 12/24 | 12/24 | | |
NCT03868592: Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis |
|
|
| Recruiting | N/A | 30 | US | Gastric sleeve/bariatric surgery | Mayo Clinic | Obesity, Morbid | 05/25 | 05/25 | | |
NCT04532814: Exercise-stimulated Muscle Glucose Uptake in Upper Body Obesity |
|
|
| Recruiting | N/A | 48 | US | Exercise | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Upper Body Obesity | 07/25 | 07/25 | | |
NCT05414578: NORDTREAT Prospective Study on Inflammatory Bowel Disease |
|
|
| Recruiting | N/A | 800 | Europe, RoW | | University of Southern Denmark, Nordic Bioscience A/S, University Hospital Bispebjerg and Frederiksberg, Aalborg University, Colitis-Crohn Foreningen, Uppsala University, Örebro University, Sweden, Lovisenberg Diakonale Hospital, University of Oslo, University of Kiel, University Hospital of Southern Denmark | Inflammatory Bowel Diseases (IBD), Crohn Disease (CD), Ulcerative Colitis (UC) | 01/24 | 01/31 | | |
